Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease Processes

Abstract

Introduction Fatigue, cognitive impairment, depression, and pain are highly prevalent symptoms in multiple sclerosis (MS). These often co-occur and may be explained by a common etiology. By reviewing existing literature, we aimed to identify potential underlying biological processes implicated in the interconnectivity between these symptoms. Methods A literature search was conducted to identify articles reporting research into the biological mechanisms responsible for the manifestation of fatigue, cognitive impairment, depression, and pain in MS. PubMed was used to search for articles published from July 2011 to July 2021. We reviewed and assessed findings from the literature to identify biological processes common to the symptoms of interest. Results Of 693 articles identified from the search, 252 were selected following screening of titles and abstracts and assessing reference lists of review articles. Four biological processes linked with two or more of the symptoms of interest were frequently identified from the literature: (1) direct neuroanatomical changes to brain regions linked with symptoms of interest (e.g., thalamic injury associated with cognitive impairment, fatigue, and depression), (2) pro-inflammatory cytokines associated with so-called ‘sickness behavior,’ including manifestation of fatigue, transient cognitive impairment, depression, and pain, (3) dysregulation of monoaminergic pathways leading to depressive symptoms and fatigue, and (4) hyperactivity of the hypothalamic–pituitary-adrenal (HPA) axis as a result of pro-inflammatory cytokines promoting the release of brain noradrenaline, serotonin, and tryptophan, which is associated with symptoms of depression and cognitive impairment. Conclusion The co-occurrence of fatigue, cognitive impairment, depression, and pain in MS appears to be associated with a common set of etiological factors, namely neuroanatomical changes, pro-inflammatory cytokines, dysregulation of monoaminergic pathways, and a hyperactive HPA axis. This association of symptoms and biological processes has important implications for disease management strategies and, eventually, could help find a common therapeutic pathway that will impact both inflammation and neuroprotection. Supplementary Information The online version contains supplementary material available at 10.1007/s40120-022-00368-2.

The role of plasma cortisol in dementia, epilepsy, and multiple sclerosis: A Mendelian randomization study

“…MS is associated with a variety of neurological symptoms ( 82 ), including sensory disturbances, visual problems, fatigue, altered balance, cognitive dysfunction, anxiety and depression ( 83 – 88 ). Many studies have shown that the HPA axis plays an important role in controlling the disease process in MS ( 89 , 90 ), and researchers have also revealed that anxiety and depression are significantly linked to higher levels of cortisol, especially in patients with relapsing-remitting MS ( 91 , 92 ). The previous findings differ from the results of our study.…”

Non-invasive brain stimulation therapy on neurological symptoms in patients with multiple sclerosis: A network meta analysis

“…And techniques targeting M1 could benefit not only fatigue, spasticity and pain as previously described, but might also improve reaction time and manual dexterity. The underlying etiology of fatigue, cognitive impairment, and pain in MS may be similar, and the overlap may be a result of lesions in MS occurring in highly interconnected deep gray matter, whereby their ripple effects may affect a variety of other brain circuits ( 59 ). It has been proposed that PwMS with impairment of hand performance may be correlated with cortico-cortical disconnections due to demyelination or a strict disruption of the motor network caused by neurodegenerative processes ( 60 ).…”

A systematic review and meta-analysis exploring the efficacy of mindfulness-based interventions on quality of life in people with multiple sclerosis

“…By contrast, MBI mechanisms in PwMS are poorly characterized and may be confounded by abnormal inflammatory mediator profile, monoamine dysfunction, neuronal injury, and network dysfunction [44,45]. Nevertheless, MBIs effectively improve stress, anxiety, depression [46], and fatigue [47] in PwMS, suggesting their potential to improve QoL.…”